Inventiva reports 2022 First Quarter Financial Information and provides clinical development update
May 16, 2022 16:00 ET | INVENTIVA
Cash position2 at €80.5m as of March 31, 2022The Group did not generate any revenue in Q1 2022Signature of a €50 million bullet credit facility agreement with the European Investment BankUpdate on...
Inventiva publie ses informations financières du 1er trimestre 2022 et fait un point sur ses développements cliniques
May 16, 2022 16:00 ET | INVENTIVA
Position de trésorerie2 à €80.5 M€ au 31 mars 2022Le Groupe n’a pas généré de chiffre d’affaires au T1 2022Obtention d’un crédit « in fine » d’un montant de 50 millions d'euros de la part de la Banque...
Inventiva secures a €50 million credit facility from the European Investment Bank
May 16, 2022 02:00 ET | INVENTIVA
This credit facility is intended to support the progress and expansion of Inventiva’s pipelineThe credit facility consists of two tranches of €25 million eachCredit agreement is part of the European...
Inventiva obtient un crédit d’un montant de 50 millions d’euros de la part de la Banque Européenne d’Investissement
May 16, 2022 02:00 ET | INVENTIVA
Ce financement doit permettre de soutenir la croissance et le développement du portefeuille de R&D d'InventivaLe crédit est composé de deux tranches de 25 millions d'euros chacune Cet accord...
Growth: Global Urinalysis Market Estimated to Surpass $4,776.9 by 2028 and Grow at 6.3% CAGR in the 2021 to 2028 Timeframe [170-Pages] | Confirmed by Research Dive
March 29, 2022 09:01 ET | Research Dive
New York, USA, March 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global urinalysis market is anticipated to gather a revenue of $4,776.9 million by 2028 and...
Global Liver Institute Leads Second Annual Rare Liver Diseases Month
February 01, 2022 10:41 ET | Global Liver Institute
Washington, DC, USA, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Global Liver Institute (GLI), a patient-led liver health nonprofit operating globally, is proud to announce today the launch of its second...
Avricore Health CEO Hosts Investor Call December 15th
December 09, 2021 13:51 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) will host a year end update and look ahead discussion by the Company’s CEO...
HealthTab™ to Offer Abbott’s i-STAT Alinity™, Expanding Chronic Disease Testing to Select Community Pharmacies in Canada
November 23, 2021 07:30 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a...
Global Liver Institute Recognized with Two Advocacy Awards for Enduring Contributions and Sustained Service
November 19, 2021 11:58 ET | Global Liver Institute
Washington, DC, USA, Nov. 19, 2021 (GLOBE NEWSWIRE) -- (Washington, DC, Friday, November 19, 2021) — Global Liver Institute (GLI), the only patient-led liver health nonprofit operating...
Sonic Incytes_Secondary_Colour.jpg
Velacur™ Data Presented at 2021 AASLD The Liver Meeting®
November 12, 2021 08:00 ET | Sonic Incytes Medical Corp.
VANCOUVER, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Sonic Incytes Medical Corp. is pleased to announce that data from its sponsored clinical study of VelacurTM – the first handheld 3D liver health...